Amador Bioscience

Amador Bioscience, Inc. is a contract research organization (CRO) that provides global-standard translational science and clinical pharmacology services to leading biopharmaceutical companies. It offers global-standard quantitative clinical pharmacology, GLP/GCLP bioanalysis, clinical research, and regulatory filing services to top biopharmaceutical companies in China, the United States, and the European Union. Amador is committed to advancing innovative drug development from discovery through clinical development and global regulatory submissions. Since its establishment in 2018, Amador Bioscience has actively supported over 80 clinical projects in the United States and China.